Biomerica, Inc. (BMRA) — Financial statements
Income statement, balance sheet, and cash flow for Biomerica, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 5↓1.9% | 5↑1.4% | 5↓71.7% | 19↑162.1% | 7 | |
| Cost of Revenue | 5↑0.2% | 5↓1.8% | 5↓69.2% | 16↑132.6% | 7 | |
| Gross Profit | 0.50↓18.5% | 0.61↑37.0% | 0.45↓85.0% | 3↑712.9% | 0.37 | |
| Operating Expenses | ||||||
| R&D Expenses | 1↓31.4% | 1↓5.9% | 2↓12.6% | 2↓17.4% | 2 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 5↓15.9% | 5↓9.8% | 6↑6.8% | 6↑0.5% | 6 | |
| Other Expenses | 0.00 | 0.00↓100.0% | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 6↓19.2% | 7↓9.0% | 8↑2.1% | 8↓4.5% | 8 | |
| Total Costs & Expenses | 10↓11.3% | 12↓6.2% | 13↓46.3% | 23↑59.2% | 15 | |
| Operating Results | ||||||
| Operating Income | -5↑19.3% | -6↑11.9% | -7↓59.3% | -5↑39.5% | -7 | |
| Depreciation & Amortization | 0.40↑7.0% | 0.37↑6.6% | 0.35↓41.0% | 0.59↑58.3% | 0.38 | |
| EBITDA | -5↑21.0% | -6↑12.8% | -7↓74.5% | -4↑44.2% | -7 | |
| EBIT | -5↑19.3% | -6↑11.9% | -7↓59.3% | -5↑39.0% | -7 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.17↓61.7% | 0.43↑224.1% | 0.13↑392.6% | 0.03↓59.4% | 0.07 | |
| Interest Income | 0.17↓61.7% | 0.43↑224.1% | 0.13↑392.6% | 0.03↓59.6% | 0.07 | |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00↓100.0% | 0.00 | |
| Non-Operating Income | 0.00 | 0.00 | 0.00↓100.0% | 0.00↑100.1% | -0.07 | |
| Other Income / Expenses | 0.17↓61.7% | 0.43↑221.6% | 0.13↑403.0% | 0.03↓59.9% | 0.07 | |
| Income Before Tax | -5↑16.2% | -6↑16.3% | -7↓57.3% | -5↑39.4% | -7 | |
| Income Tax Expense | 0.00↓97.6% | 0.04↓17.6% | 0.05↑115.0% | 0.02↑81.7% | 0.01 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -5↑16.8% | -6↑16.3% | -7↓57.6% | -5↑39.2% | -7 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -5↑16.8% | -6↑16.3% | -7↓57.6% | -5↑39.2% | -7 | |
| Bottom-Line Net Income | -5↑16.8% | -6↑16.3% | -7↓57.6% | -5↑39.2% | -7 | |
| EPS (Basic) | -2.16↓500.0% | -0.36↑28.0% | -0.50↓38.9% | -0.36↑33.3% | -0.54 | |
| EPS (Diluted) | -2.16↓500.0% | -0.36↑28.0% | -0.50↓38.9% | -0.36↑33.3% | -0.54 | |
| Weighted Average Shares | 2↓86.3% | 17↑18.8% | 14↑11.7% | 13↑6.2% | 12 | |
| Weighted Average Diluted Shares | 2↓86.3% | 17↑18.8% | 14↑11.7% | 13↑6.2% | 12 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.